Finerenone for Patients With Primary Aldosteronism (FAIRY) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Finerenone for Patients With Primary Aldosteronism (FAIRY) — Stella

Home/Primary Aldosteronism/

View on ClinicalTrials.gov

Recruiting

Back to Primary Aldosteronism trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

the first affiliated hospital of Chongqing medical university, Chongqing, Chongqing Municipality

Key details

Phase

Post-approval study

Sponsor

Qifu Li

Collaborators

The Affiliated Hospital Of Southwest Medical University, The First Affiliated Hospital of Zhengzhou University

Enrollment target

~306 participants

Started

June 2024

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years – 75 Years

Last updated August 2024